MRGX3 Inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the MRGX3 receptor, a member of the Mas-related G-protein-coupled receptor (MRGPR) family. MRGX3, like other MRGPR family members, is involved in various cellular signaling pathways, particularly those related to sensory perception, including the modulation of pain and itch sensations. These receptors are G-protein-coupled receptors (GPCRs), which, upon activation, trigger a cascade of intracellular signaling events through the coupling with G-proteins, ultimately leading to physiological responses. MRGX3 Inhibitors function by binding to specific sites on the MRGX3 receptor, either at the orthosteric binding site, where endogenous ligands typically bind, or at allosteric sites that modulate receptor activity. This binding prevents the receptor from undergoing the conformational changes necessary to activate the associated G-proteins, thereby blocking the downstream signaling pathways.
The design and effectiveness of MRGX3 Inhibitors depend on their chemical structure and properties. These inhibitors are typically engineered to interact with the unique structural features of the MRGX3 receptor, such as its transmembrane helices, which form the ligand-binding pocket, or other critical regions involved in receptor activation. The molecular design of these inhibitors often includes hydrophobic regions that fit within the transmembrane domain and polar or charged groups that can form hydrogen bonds or ionic interactions with key residues in the receptor. The inhibitors are also optimized for solubility, stability, and bioavailability to ensure they can effectively reach and bind to MRGX3 in the cellular environment. Additionally, the kinetics of binding, including the rates of association and dissociation, are critical factors in determining the duration and potency of the inhibitory effect. By studying the interactions between MRGX3 Inhibitors and the receptor, researchers can gain valuable insights into the molecular mechanisms underlying GPCR signaling and the specific role of MRGX3 in sensory modulation and other cellular processes. Understanding these interactions is essential for elucidating the broader physiological functions of MRGX3 and its place within the GPCR signaling network.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to downregulate the transcription of various genes by inhibiting the activation of transcription factors such as NF-kappaB. This inhibition could extend to the MRGX3 gene, potentially decreasing its expression in sensory neurons. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may decrease MRGX3 expression by enhancing the deacetylation activity of sirtuins, which can lead to the suppression of gene transcription, including genes related to GPCR signaling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane could downregulate MRGX3 expression by activating Nrf2, which can initiate the transcription of genes involved in cellular defense mechanisms, potentially leading to the repression of other non-related genes such as MRGX3. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin has the potential to decrease MRGX3 expression by stabilizing the cellular redox environment, which in turn can lead to the suppression of pro-inflammatory transcription factors that may be driving MRGX3 gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate can reduce MRGX3 expression by altering DNA methylation and histone acetylation states, leading to a condensed chromatin structure around the MRGX3 promoter region, thereby hindering its transcription. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein may inhibit MRGX3 expression by acting as an estrogen receptor modulator, which can result in the altered transcription of certain genes, including those coding for GPCRs, by changing the conformation of estrogen-responsive promoter regions. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin could downregulate MRGX3 expression by desensitizing sensory neurons and reducing the neuronal demand for MRGX3 synthesis, which would reduce the overall transcriptional load of this gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may decrease MRGX3 expression by binding to its nuclear receptors, which can alter the transcriptional activity of genes involved in cell differentiation and proliferation, potentially including sensory neuron-specific genes like MRGX3. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could inhibit MRGX3 expression by binding to glucocorticoid receptors, which can translocate to the nucleus and downregulate pro-inflammatory gene transcription, potentially affecting MRGX3 if it is regulated by similar pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may reduce MRGX3 expression by elevating intracellular cAMP levels, which can activate PKA and lead to the phosphorylation and deactivation of transcription factors that normally promote MRGX3 gene transcription. | ||||||